Open AccessMetformin: new perspectives in chemoprevention and therapy of cancer
Author(s) -
А. А. Шестаков,
Т. В. Саприна,
И. А. Ануфрак,
О. Э. Гончикова,
А. Л. Чернышева
Publication year - 2018
Publication title -
rossijskij bioterapevtičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 1726-9792
pISSN - 1726-9784
DOI - 10.17650/1726-9784-2018-17-3-12-19
Subject(s) - metformin , medicine , context (archaeology) , cancer , oncology , cancer therapy , pharmacology , intensive care medicine , geography , insulin , archaeology
According to modern data, metformin is a unique drug, which can act not only as sugar-reducing medicine, but also as an antiproliferative element. More and more new researches about metformin effects in oncologic patients appear during last decades. A lot of researchers suppose that metformin is a new promising medicine for chemopreventive and neoadjuvant cancer therapy. This literature review covers current researches of metformin in context of it»s possible antiproliferative effects.